🔎 Trials Near Me

Почетна › Рак дојке › Пенсилванија › Pittsburgh

Kliničke studije za Рак дојке u gradu Pittsburgh, PA

42 studija za Рак дојке traži učesnike na lokacijama u gradu Pittsburgh i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

Тражи се учесникФаза 3
  • Magee Womens Hospital, Pittsburgh
Узраст 18 и старији · Жене · Ажурирано 12. 11. 2026. · NCT07541079

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Тражи се учесникФаза 1
  • UPMC Hillman Cancer Center, Pittsburgh
Узраст 12 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05372640

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Тражи се учесникФаза 1/2
  • Research Facility, Pittsburgh
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT06590857

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Тражи се учесникФаза 1
  • UPMC Hillman Cancer Center, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07029399

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Тражи се учесник
  • Allegheny (AHN), Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07214532

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Тражи се учесникФаза 3
  • UPMC Hillman Cancer Center - Magee-Women?s Hospital, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06790693

E-Mindfulness Approaches for Living After Breast Cancer

Тражи се учесникФаза 3
  • UPMC-Magee Womens Hospital, Pittsburgh
  • UPMC-Saint Margaret, Pittsburgh
  • UPMC Hillman Cancer Center, Pittsburgh
  • и још 2
Узраст од 18 до 50 · Оба пола · Ажурирано 4. 11. 2026. · NCT06748222

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Тражи се учесникФаза 1/2
  • Allegheny Health Network, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05579366

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Тражи се учесникФаза 1
  • University of Pittsburgh Medical Center, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07114601

Distance-Based Exercise to Preserve Function and Prevent Disability

Тражи се учесник
  • UPMC-Magee Womens Hospital, Pittsburgh
  • UPMC Hillman Cancer Center, Pittsburgh
  • UPMC-Passavant Hospital, Pittsburgh
  • и још 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07059884

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Тражи се учесникФаза 3
  • Allegheny General Hospital, Pittsburgh
  • UPMC-Magee Womens Hospital, Pittsburgh
  • West Penn Hospital, Pittsburgh
  • и још 10
Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Тражи се учесникФаза 3
  • University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0058), Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07060807

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Тражи се учесникФаза 1
  • University of Pittsburgh Medical Center, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07524322

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Тражи се учесникФаза 1
  • UPMC, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06774963

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Тражи се учесникОпсервациона студија
  • UPMC Magee - Womens Hospital, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06401421

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Тражи се учесникФаза 1/2
  • UPMC - Hillman Cancer Center, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07100106

The Cancer of the Pancreas Screening-5 CAPS5)Study

Тражи се учесникФаза 3
  • University of Pittsburgh, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT02000089

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Тражи се учесникФаза 1/2
  • Research Site, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05123482

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Тражи се учесникФаза 3
  • UPMC Hillman Cancer Center, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06757634

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Тражи се учесникФаза 1/2
  • University of Pittsburgh Medical Center, Pittsburgh
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Тражи се учесникФаза 2
  • University of Pittsburgh (UPMC), Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06369285

Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning

Тражи се учесникОпсервациона студија
  • Allegheny General Hospital, Pittsburgh
Узраст од 20 до 89 · Жене · Ажурирано 30. 9. 2026. · NCT07023887

A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer

Тражи се учесник
  • AHN Allegheny General Hospital, Pittsburgh
  • Allegheny General Hospital, Pittsburgh
Узраст од 20 до 89 · Жене · Ажурирано 30. 9. 2026. · NCT07698314

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Тражи се учесникФаза 1
  • Research Site, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT05877599

EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer

Тражи се учесник
  • AHN Allegheny General Hospital, Pittsburgh
  • AHN Allegheny General Hospital, Pittsburgh
Узраст од 20 до 89 · Жене · Ажурирано 28. 9. 2026. · NCT07704476

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Тражи се учесник
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Узраст 30 и старији · Жене · Ажурирано 25. 9. 2026. · NCT02945579

Identifying Patterns in the Breath of Individuals With Breast Cancer

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Weinstein Imaging Associates, Pittsburgh
Узраст од 40 до 74 · Жене · Ажурирано 18. 9. 2026. · NCT06512350

Active Surveillance in Older Women With ER+ Breast Cancer

Тражи се учесникОпсервациона студија
  • University of Pittsburgh Medical Center, Pittsburgh
Узраст 70 и старији · Жене · Ажурирано 11. 9. 2026. · NCT07262138

ATEMPT 2.0: Adjuvant T-DM1 vs TH

Тражи се учесникФаза 2
  • University of Pittsburgh Medical Center Cancer UPMC- Magee Women's Hospital, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT04893109

Biennial CEM in Women With a Personal History of Breast Cancer

Тражи се учесникЗдраве особе су добродошле
  • Magee-Womens Hospital, Pittsburgh
  • Hillman Cancer Center at Shadyside, Pittsburgh
  • UPMC Magee-Womens Imaging - Bethel Park, Bethel Park · 8 ми удаљено
  • и још 3
Узраст од 30 до 79 · Жене · Ажурирано 19. 8. 2026. · NCT06105749

EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer

Тражи се учесник
  • AHN Allegheny General Hospital, Pittsburgh
Узраст од 20 до 89 · Жене · Ажурирано 17. 8. 2026. · NCT07739563

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Тражи се учесникФаза 2/3
  • Local Institution - 0360, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT06926868

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Тражи се учесник
  • University of Pittsburgh, Pittsburgh
Узраст 65 и старији · Жене · Ажурирано 17. 7. 2026. · NCT05535192

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Тражи се учесникФаза 1
  • University of Pittsburg Medical Center (UPCM), Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 11. 6. 2026. · NCT05283330

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Тражи се учесникФаза 1
  • UPMC Hillman Cancer Center, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 8. 6. 2026. · NCT04890613

Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum

Тражи се учесникОпсервациона студија
  • UPMC St. Margaret, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 7. 5. 2026. · NCT01042548

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Тражи се учесникФаза 3
  • Allegheny General Hospital, Pittsburgh
  • West Penn Hospital, Pittsburgh
  • Jefferson Hospital, Jefferson Hills · 11 ми удаљено
  • и још 3
Узраст од 50 до 70 · Оба пола · Ажурирано 23. 4. 2026. · NCT04852887

A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients

Тражи се учесникОпсервациона студија
  • UPMC Magee Womens Hospital, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 18. 3. 2026. · NCT06833853

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Тражи се учесникОпсервациона студија
  • Allegheny Health Network, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 5. 3. 2026. · NCT04075305

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

Тражи се учесник
  • Allegheny General Hospital, Pittsburgh
Узраст од 20 до 89 · Жене · Ажурирано 4. 2. 2026. · NCT06115486

Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

Тражи се учесник
  • Allegheny General Hospital, Pittsburgh
Узраст од 20 до 89 · Жене · Ажурирано 3. 2. 2026. · NCT06858449

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Тражи се учесникОпсервациона студија
  • Allegheny Health Network, Pittsburgh
  • University of Pittsburgh Medical Centers, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2025. · NCT03053193

Studije za Рак дојке u drugim gradovima

Ostale studije u gradu Pittsburgh

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.